Computational Modeling of Fructose Metabolism and Development in NAFLD
Non-alcohol fatty liver disease (NAFLD) is a common disorder that has increased in prevalence 20-fold over the last three decades. It covers a spectrum of conditions resulting from excess lipid accumulation in the liver without alcohol abuse. Among all the risk factors, over-consumption of fructose...
Main Authors: | Yunjie Liao, Nathan A. Davies, I. David L. Bogle |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2020.00762/full |
Similar Items
-
Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
by: Mattia Coronati, et al.
Published: (2022-03-01) -
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
by: Jemy A. Gutierrez, et al.
Published: (2021-06-01) -
A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma
by: Brittany Dewdney, et al.
Published: (2020-03-01) -
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
by: Emma L. Shepherd, et al.
Published: (2021-04-01) -
Fructose Consumption and Hepatocellular Carcinoma Promotion
by: Lisette Chávez-Rodríguez, et al.
Published: (2021-11-01)